Long term efficacy and safety of conversion to mycophenolate mofetil in stable liver transplant recipients with calcineurin inhibitor-induced renal dysfunction

被引：0
|
作者：
Koch, RO [1 ]
Graziadei, IW [1 ]
Schulz, F [1 ]
Nachbaur, K [1 ]
Koenigsrainer, A [1 ]
Margreiter, R [1 ]
Vogel, W [1 ]
机构：
[1] Univ Innsbruck, A-6020 Innsbruck, Austria
来源：
LIVER TRANSPLANTATION | 2003年 / 9卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
317
引用
收藏
页码：C80 / C80
页数：1
相关论文
共 50 条
  • [31] Two yr mycophenolate mofetil plus low-dose calcineurin inhibitor for renal dysfunction after liver transplant
    Biselli, Maurizio
    Vitale, Giovanni
    Gramenzi, Annagiulia
    Riili, Anna
    Berardi, Sonia
    Camma, Carlo
    Scuteri, Alessandra
    Morelli, Maria Cristina
    Grazi, Gian Luca
    Pinna, Antonio Daniele
    Andreone, Pietro
    Bernardi, Mauro
    [J]. CLINICAL TRANSPLANTATION, 2009, 23 (02) : 191 - 198
  • [32] Withdrawal of Mycophenolate Mofetil in stable renal transplant recipients.
    Meier-Kriesche, HU
    Kaza, H
    Thambuganipalle, R
    Vaghela, M
    Jacobs, HG
    Mulgaonkar, SP
    Friedman, GS
    Kaplan, B
    [J]. TRANSPLANTATION, 2000, 69 (08) : S132 - S132
  • [33] CONVERSION OF STABLE ABO-INCOMPATIBLE KIDNEY TRANSPLANT RECIPIENTS FROM MYCOPHENOLATE MOFETIL WITH STANDARD EXPOSURE CALCINEURIN INHIBITOR TO EVEROLIMUS WITH VERY LOW EXPOSURE CALCINEURIN INHIBITOR
    Uchida, Junji
    Machida, Yuichi
    Kabei, Kazuya
    Iwai, Tomoaki
    Kuwabara, Nobuyuki
    Naganuma, Toshihide
    Kumada, Norihiko
    Nakatani, Tatsuya
    [J]. TRANSPLANT INTERNATIONAL, 2013, 26 : 248 - 248
  • [34] Calcineurin Inhibitor Sparing with Mycophenolate Mofetil in Liver Transplant Recipients: A Systematic Review and Meta-Analysis
    Goralczyk, Armin D.
    Bari, Narin
    Abu-Aja, Wijdan
    Lorf, Thomas
    Ramadori, Giuliano
    Friede, Tim
    Obed, Aiman
    [J]. LIVER TRANSPLANTATION, 2012, 18 : S187 - S187
  • [35] Pharmacokinetics of mycophenolate mofetil in stable pediatric liver transplant recipients receiving mycophenolate mofetil and cyclosporine
    Lobritto, Steven J.
    Rosenthal, Philip
    Bouw, Rene
    Leung, Mimi
    Snell, Paul
    Mamelok, Richard D.
    [J]. LIVER TRANSPLANTATION, 2007, 13 (11) : 1570 - 1575
  • [36] Conversion to combined therapy with sirolimus and mycophenolate mofetil improved renal function in stable renal transplant recipients
    Tsai, Meng-Kun
    Lee, Chih-Yuan
    Hu, Rey-Heng
    Lee, Po-Huang
    [J]. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2007, 106 (05) : 372 - 379
  • [37] Calcineurin Inhibitor Sparing with Mycophenolate Mofetil in Liver Transplant Recipients: A Systematic Review and Meta-Analysis
    Goralczyk, A. D.
    Abu-Ajaj, W.
    Bari, N.
    Lorf, T.
    Ramadori, G.
    Friede, T.
    Obed, A.
    [J]. TRANSPLANTATION, 2012, 94 (10) : 745 - 745
  • [38] Safety and efficacy of tacrolimus in combination with mycophenolate mofetil (MMF) in cadaveric renal transplant recipients
    Miller, J
    Mendez, R
    Pirsch, JD
    Jensik, SC
    [J]. TRANSPLANTATION, 2000, 69 (05) : 875 - 880
  • [39] Sirolimus and mycophenolate mofetil for calcineurin-free immunosuppression in renal transplant recipients
    Pescovitz, MD
    Govani, M
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (04) : S16 - S21
  • [40] CONVERSION TO MYCOPHENOLATE MOFETIL COMBINED WITH LOW-DOSE OF CALCINEURIN INHIBITORS IN LIVER TRANSPLANT PATIENTS WITH CHRONIC RENAL DYSFUNCTION.
    Cristina, Ponton E.
    Luis, Vizcaino
    Santiago, Tome
    Javier, Castroagudin
    Esteban, Otero
    Ester, Molina
    Jesus, Hermida
    Ana, Lopez
    Perez Evaristo, Varo
    [J]. LIVER TRANSPLANTATION, 2008, 14 (07) : S104 - S104
12345